May 4-7, 2016
Arthrogen's COO Janneke Meulenberg, PhD and CEO Robert Jan Lamers to be present at the Annual Meeting of the American Society of Gene & Cell therapy in Washington, www.asgct.org
March 31 - April 3, 2016
Arthrogen's Lisette Bevaart, PhD, to be present at the Osteoarthritis Research Society International 2016 World Congress in Amsterdam
Today, Friday March 11 2016, Caroline Aalbers, PhD, received the Greiner Award at the NVGCT Spring Symposium for her thesis “Gene Therapy for arthritis: progress towards a clinical trial”. The Greiner Award is a yearly awarded prize for the best thesis or publication in gene therapy. Caroline performed her research for the thesis during her employment at Arthrogen, with the founder of Arthrogen Prof. P.P. Tak as her promoter. We would like to congratulate Caroline with this great honor and reward.
Arthrogen’s Lisette Bevaart, PhD, to present at the “Gene Therapy Clinical Trials in the Netherlands” session of the NVGCT Symposium.
11-15 January Arthrogen will be present in San Francisco during the JP Morgan and will meet with a numerous partners and companies.